We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

78 hedge funds and large institutions have $243M invested in Tempest Therapeutics in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $237M → $243M (+$5.44M)

13% less funds holding

Funds holding: 90 → 78 (-12)

19% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 21

48% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 25

71% less call options, than puts

Call options by funds: $2.04M | Put options by funds: $7.04M

Holders
78
Holders Change
-12
Holders Change %
-13.33%
% of All Funds
2.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
17
Reduced
21
Closed
25
Calls
$2.04M
Puts
$7.04M
Net Calls
-$5M
Net Calls Change
-$4.37M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$4.78M
2
BFA
BlackRock Fund Advisors
California
+$3.79M
3
Goldman Sachs
Goldman Sachs
New York
+$3.17M
4
ARTA
A.R.T. Advisors
New York
+$1.48M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$15.8M
2
Jennison Associates
Jennison Associates
New York
-$9.43M
3
EA
Emerald Advisers
Pennsylvania
-$3.43M
4
GIM
Granahan Investment Management
Massachusetts
-$3.42M
5
SM
Sabby Management
Florida
-$3.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$229K +$33K +1 +14%
Millennium Management
52
Millennium Management
New York
$189K – – –
MLICM
53
Metropolitan Life Insurance Company (MetLife)
New York
$162K – – –
NFA
54
Nationwide Fund Advisors
Ohio
$149K – – –
NCMW
55
Northern Capital Management (Wisconsin)
Wisconsin
$146K +$165K +5 New
Squarepoint
56
Squarepoint
New York
$142K +$165K +5 New
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
$140K +$165K +5 New
Deutsche Bank
58
Deutsche Bank
Germany
$136K -$1.02M -31 -86%
AIG
59
American International Group
New York
$134K – – –
UBS Group
60
UBS Group
Switzerland
$119K -$98.9K -3 -43%
State Board of Administration of Florida Retirement System
61
State Board of Administration of Florida Retirement System
Florida
$116K – – –
VOYA Investment Management
62
VOYA Investment Management
Georgia
$112K – – –
EA
63
Emerald Advisers
Pennsylvania
$109K -$3.43M -104 -96%
BA
64
BlackRock Advisors
Delaware
$98K -$66K -2 -40%
Balyasny Asset Management
65
Balyasny Asset Management
Illinois
$98K +$98.9K +3 New
BGIM
66
Brandywine Global Investment Management
Pennsylvania
$85K +$33K +1 +50%
Morgan Stanley
67
Morgan Stanley
New York
$78K -$396K -12 -80%
Group One Trading
68
Group One Trading
Illinois
$67K -$692K -21 -91%
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$51.7K – – –
BG
70
BlackRock Group
United Kingdom
$44K – – –
Canada Life
71
Canada Life
Manitoba, Canada
$34K – – –
CLOS
72
Compagnie Lombard Odier SCmA
Switzerland
$33K +$33K +1 New
Barclays
73
Barclays
United Kingdom
$30K -$495K -15 -94%
Legal & General Group
74
Legal & General Group
United Kingdom
$24K – – –
PAM
75
Panagora Asset Management
Massachusetts
$24K +$33K +1 New
1 2
3
4 5

TPST Hedge Fund Activity: Q4 2015 in Review

78 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2015, worth a combined $243M — up 2.3% from $237M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of TPST and 13 opened new positions — a net loss of 12 holders — while 21 trimmed existing stakes and 17 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $4.78M. The largest seller was State Street, cutting an estimated $15.8M.

  • 78 institutional investors held Tempest Therapeutics (TPST) as of Q4 2015, down from 90 in Q3 2015.
  • Funds reported $243M of Tempest Therapeutics stock for Q4 2015, up 2.3% quarter-over-quarter.
  • 13 funds opened new Tempest Therapeutics positions in Q4 2015 and 25 closed out, a net change of -12 holders.
  • The largest Tempest Therapeutics buyer in Q4 2015 was EcoR1 Capital, an estimated $4.78M added.
  • The largest Tempest Therapeutics seller in Q4 2015 was State Street, an estimated $15.8M sold.

Based on aggregated 13F filings for Q4 2015.